← Latest papers
🧬 biology

Transient architecture of the embryonic pancreas determines endocrine mass

This study demonstrates that the transient lumenal plexus architecture of the embryonic pancreas actively instructs cell fate decisions through the mechanosensitive Hippo pathway regulator Merlin, which coordinates polarized membrane trafficking and restrains PI3K signaling to ensure proper lineage allocation and adult endocrine mass.

Original authors: Ondine Cleaver, Neha Ahuja, Christopher Chaney, Tyler Bierschenk, Tuli Pramanik, Austin Mills, Peter Luo, Mitzy Cowdin, Jinlong Lin, Jun Tsunezumi, Kevin Dean, Denise Marciano, Thomas Carroll

Published 2026-09-14
📖 5 min read🧠 Deep dive

Original authors: Ondine Cleaver, Neha Ahuja, Christopher Chaney, Tyler Bierschenk, Tuli Pramanik, Austin Mills, Peter Luo, Mitzy Cowdin, Jinlong Lin, Jun Tsunezumi, Kevin Dean, Denise Marciano, Thomas Carroll

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The human body is built from tissues that must take on very specific shapes to work correctly. In the developing embryo, a flat sheet of cells called an epithelium folds and stretches to form hollow tubes and complex organs. This process, known as organogenesis, is not just about building a structure; the shape of the tissue itself seems to tell the cells inside it what to become. For example, in the pancreas, a temporary network of tiny tubes forms before the organ is fully grown. Scientists have long wondered if this fleeting architectural stage is merely a byproduct of growth or if it actively instructs cells to turn into the hormone-producing units needed to regulate blood sugar. If the shape of the tissue is a command center for cell identity, then a defect in how that shape forms could lead to a lifetime of metabolic problems, even if the cells themselves are genetically healthy.

A team of researchers at the University of Texas Southwestern Medical Center has now uncovered a critical link between this temporary tissue shape and the final number of insulin-producing cells in the adult pancreas. They focused on a protein called Merlin, which acts as a sensor for the physical environment of cells. By studying mice where the gene for Merlin was removed specifically in the pancreas, the researchers found that without this protein, the embryonic pancreas fails to build its essential temporary network of tubes. Instead of forming a complex, branching plexus of hollow spaces, the tissue remains a thick, disorganized stack of cells. This failure to reshape the tissue has a profound consequence: the cells that should become the pancreas's digestive enzymes or its blood-sugar-regulating hormones are misdirected. The result is an adult pancreas with far fewer insulin-producing cells and a reduced ability to manage glucose levels.

The study reveals that the problem is not that the individual cells lack the instructions to become specific types. When the researchers created a situation where only a small fraction of cells lacked Merlin, the rest of the tissue developed normally, and the mutant cells themselves adopted the correct fates. This proved that the defect was not a personal failure of the cell but a failure of the neighborhood. The tissue architecture itself acts as an instructive niche. When the architecture is broken, the entire community of cells receives the wrong signals. In the mutant mice, the tissue remained stuck in a stratified state, unable to clear out the inner layers to form the hollow tubes necessary for the pancreas to function. This structural blockage prevented the proper formation of the pancreatic plexus, a transient structure that serves as a incubator for future hormone-producing cells. Without this specific architectural stage, the organ could not generate the full complement of beta cells needed for a healthy adult life.

To understand how Merlin guides this process, the researchers looked at what happens inside the cells. They discovered that Merlin is essential for a specific type of cellular logistics: the movement of vesicles, or tiny bubbles, that carry building materials to the surface of the cell. In a healthy embryo, these vesicles deliver proteins to the center of a cell cluster to form a new hollow space, a process called de novo lumen formation. In the absence of Merlin, this delivery system breaks down. The proteins meant for the center of the tube get lost inside the cell, and the hollow spaces either never form or become abnormally large and dilated. The researchers found that Merlin normally keeps a signaling pathway called PI3K in check. When Merlin is missing, PI3K becomes overactive, causing the vesicle traffic to go haywire. By using drugs to block this overactive pathway, the researchers were able to partially restore the ability of the mutant tissue to form tubes, confirming that the structural defect was driven by this specific molecular imbalance.

The findings suggest that the pancreas relies on a precise window of time during embryonic development to establish its final cell count. Once this temporary plexus forms and then resolves, the number of insulin-producing cells is largely set. The study shows that Merlin is the key regulator that ensures this architectural stage happens correctly. It does this by sensing the physical state of the tissue and coordinating the internal transport systems that build the hollow tubes. If this coordination fails, the tissue cannot transition from a solid mass to a functional, branched organ. The research also clarifies that Merlin's role is distinct from its known function in controlling cell growth; here, it is strictly about the physical construction of the organ's shape. The study rules out the idea that the loss of insulin-producing cells is due to the cells dying or failing to divide; instead, the cells are simply unable to receive the correct environmental cues because the physical structure they rely on never materialized.

This work changes how we view the development of complex organs. It suggests that the physical shape of a tissue is not just a passive result of cell division but an active teacher that determines cell fate. The transient plexus of the embryonic pancreas is not a random arrangement of cells but a necessary scaffold that instructs the future of the organ. If this scaffold is compromised, the organ's capacity to function in adulthood is permanently altered. The researchers demonstrated that the adult pancreas's ability to regulate blood sugar is determined by a brief, mechanical event in the embryo. By linking a mechanical sensor, a transport system, and a temporary tissue shape, the study provides a clear picture of how a physical defect can lead to a lifelong metabolic condition. The results highlight that the architecture of an organ is a fundamental determinant of its health, and that understanding these early structural events is crucial for grasping the origins of diseases like diabetes.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →